NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
1-Year Est. Return
12.08%
1 Year Est. Return
+12.08%
AUM
$1.31B
AUM Growth
-$337M
(-20%)
Holding
34
Top Buys
| 1 | +$10.6M | |
| 2 | +$10.6M | |
| 3 | +$7.7M | |
| 4 |
ArriVent BioPharma
AVBP
|
+$6.5M |
| 5 |
Vaxcyte
PCVX
|
+$6.23M |
Top Sells
| 1 | +$138M | |
| 2 | +$24.5M | |
| 3 | +$24M | |
| 4 |
Alibaba
BABA
|
+$10.6M |
| 5 |
Mersana Therapeutics
MRSN
|
+$6.08M |
Sector Composition
| 1 | Healthcare | 50.89% |
| 2 | Technology | 14.07% |
| 3 | Financials | 9.29% |
| 4 | Consumer Discretionary | 3.75% |
| 5 | Industrials | 0.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
LanzaTech
LNZA
$38.9M
| $3.83M | 0.29% |
158,148
|
|
||
27
IO Biotech
IOBT
$56.4M
| $3.66M | 0.28% |
3,354,449
|
|
||
28
Kyverna Therapeutics
KYTX
$272M
| $3.57M | 0.27% |
1,850,000
|
|
||
29
AbCellera Biologics
ABCL
$1.1B
| $2.51M | 0.19% |
1,126,915
|
|
||
30
Marqeta
MQ
$2B
| $1.82M | 0.14% |
441,558
|
|
||
31
Galecto
GLTO
$6.79M
| $310K | 0.02% |
99,913
|
|
||
|
32
Mersana Therapeutics
MRSN
$39.4M
| – | – |
-170,000
|
|
||
|
TEM
33
Tempus AI
TEM
$12.2B
| – | – |
-4,074,419
|
|
||
|
CRGX
34
DELISTED
CARGO Therapeutics
CRGX
| – | – |
-1,663,724
|
|